Woodcock: Pending ORA reorg will “modify things significantly” for all FDA regulated products

Woodcock: Pending ORA reorg will “modify things significantly” for all FDA regulated products

Source: 
RAPS.org
snippet: 

A proposed reorganization of the Food and Drug Administration Office of Regulatory Affairs (ORA) will “modify things significantly” for foods as well as medical products and is expected to be finalized this fall, said Janet Woodcock, the agency’s principal deputy commissioner at a 2 March webinar sponsored by the Alliance for a Stronger FDA.